Dr. Huang received his Ph.D. from MIT (Nuclear Science and Engineering). He performed his postdoctoral work at MGH/HMS. His current research thrust is to high-throughput screen and design, synthesize, and characterize targeted theranostic compounds for human diseases such as Alzheimerâs disease, Parkinsonâs disease, cancer, etc. In addition, his lab is exploring novel applications of biomedical informatics (such as medical image analysis and bioinformatics) and cheminformatics (such as structure-based rational drug design and in-silico drug screening) in systems biology and nanotechnology in translational medicine. Dr. Huang serves on scientific advisory and editorial boards for several research foundations and scientific journals.